Dr. Huang received his Ph.D. from MIT (Nuclear Science and Engineering). He performed his postdoctoral work at MGH/HMS. His current research thrust is to high-throughput screen and design, synthesize, and characterize targeted theranostic compounds for human diseases such as Alzheimerâs disease, Parkinsonâs disease, cancer, etc. In addition, his lab is exploring novel applications of biomedical informatics (such as medical image analysis and bioinformatics) and cheminformatics (such as structure-based rational drug design and in-silico drug screening) in systems biology and nanotechnology in translational medicine. Dr. Huang serves on scientific advisory and editorial boards for several research foundations and scientific journals.